DavidL.HornMD

PubMed

• 4 citations
  Percutaneous versus open reduction and fixation for Tillaux and triplane fractures: a multicenter cohort comparison study.
  William Zelenty, Richard S. Yoon, Lior Shabtai, Paul D. Choi, Benjamin D. Martin, David Horn, David S. Feldman, Norman Y. Otsuka, David H. Godfried> ;Journal of Pediatric Orthopedics. Part B. 2018 Nov 1
• 6 citations
  Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy
  Jorge Zorzopulos, Steven M. Opal, Andrés Hernando-Insúa, Juan M. Rodríguez, Fernanda Elías, Juan Fló, Ricardo A. López, Norma Alejandra Chasseing, Victoria Lux-Lantos,...> ;World Journal of Stem Cells. 2017 Mar 26
• 13 citations
  Hospital resource use of patients receiving isavuconazole vs voriconazole for invasive mold infections in the phase III SECURE trial.
  David Horn, Debra A. Goff, Nikhil Khandelwal, James Spalding, Nkechi Azie, Fei Shi, Billy Franks, Andrew F. Shorr> ;Journal of Medical Economics. 2016 Mar 30
• 13 citations
  PyNTTTTGT and CpG Immunostimulatory Oligonucleotides: Effect on Granulocyte/Monocyte Colony-Stimulating Factor (GM-CSF) Secretion by Human CD56+ (NK and NKT) Cells
  Juan J. Rodriguez, José Marchicio, Mariela López, Andrea Ziblat, Fernanda Elías, Juan Fló, Ricardo López, David Horn, Jorge Zorzopulos, Alejandro D. Montaner> ;Plos One. 2015 Feb 23
• 9 citations
  The Novel Immunotherapeutic Oligodeoxynucleotide IMT504 Protects Neutropenic Animals from Fatal Pseudomonas aeruginosa Bacteremia and Sepsis
  Abdullah Chahin, Steven M. Opal, Jorge Zorzopulos, David V. Jobes, Yazan Migdady, Michelle Yamamoto, Nicholas A. Parejo, John E. Palardy, David L. Horn> ;Antimicrobial Agents and Chemotherapy. 2015 Feb 1
• 50 citations
  Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance(®) registry.
  David Horn, Alison G. Freifeld, Mindy G. Schuster, Nkechi Azie, Billy Franks, Carol A. Kauffman> ;Mycoses. 2014 Nov 1
• 8 citations
  Non-clinical safety studies of IMT504, a unique non-CpG oligonucleotide
  Raul Franco, Juan M. Rodríguez, Fernanda Elías, Andrés Hernando-Insúa, Juan Fló, Ricardo A. López, Carlos A. Nagle, Néstor Lago, Jorge Zorzopulos, David L. Horn, Aleja...> ;Nucleic Acid Therapeutics. 2014 Jul 23
• 276 citations
  Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registr...
  Michael A. Pfaller, David R. Andes, Daniel J. Diekema, David Horn, Annette C. Reboli, Coleman Rotstein, Billy Franks, Nkechi Azie> ;Plos One. 2014 Jul 3
• 48 citations
  Prospective antifungal therapy (PATH) alliance(®) : focus on mucormycosis.
  Dimitrios P. Kontoyiannis, Nkechi Azie, Billy Franks, David Horn> ;Mycoses. 2014 Apr 1
• 8 citations
  The Prospective Antifungal Therapy Alliance® registry: A two-centre Canadian experience
  Shariq Haider, Coleman Rotstein, David Horn, Michel Laverdière, Nkechi Azie> ;The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale. 2014 Jan 1
• 18 citations
  Treatment and outcomes of Candida osteomyelitis: review of 53 cases from the PATH Alliance® registry
  Dionissios Neofytos, Shirish Huprikar, Annette C. Reboli, Mindy G. Schuster, Nkechi Azie, Billy Franks, David Horn> ;European Journal of Clinical Microbiology & Infectious Diseases. 2014 Jan 1
• 11 citations
  Aleuria Aurantia Lectin (AAL)-Reactive Immunoglobulin G Rapidly Appears in Sera of Animals following Antigen Exposure
  Songming Chen, Chen Lu, Hongbo Gu, Anand Mehta, Jianwei Li, Patrick B. Romano, David Horn, D. Craig Hooper, Carthene R. Bazemore-Walker, Timothy M. Block> ;Plos One. 2012 Sep 14
• 20 citations
  Inhibitors of human histone deacetylase with potent activity against the African trypanosome Trypanosoma brucei
  John M. Kelly, Martin C. Taylor, David Horn, Einars Loza, Ivars Kalvinsh, Fredrik Björkling> ;Bioorganic & Medicinal Chemistry Letters. 2012 Mar 1
• 42 citations
  Pathologic lower extremity fractures in children with Alagille syndrome.
  Christina B Bales, Binita M. Kamath, Pedro S Munoz, Alexander Nguyen, David A. Piccoli, Nancy B. Spinner, David Horn, Justine Shults, Mary B. Leonard, Adda Grimberg, K...> ;Journal of Pediatric Gastroenterology and Nutrition. 2010 Jul 1
• 54 citations
  Factors related to survival and treatment success in invasive candidiasis or candidemia: a pooled analysis of two large, prospective, micafungin trials
  David Horn, Luis Ostrosky-Zeichner, Michele I. Morris, Andrew J. Ullmann, Chunzhang Wu, Donald N. Buell, Laura L. Kovanda, Oliver A. Cornely> ;European Journal of Clinical Microbiology & Infectious Diseases. 2010 Feb 1
• 37 citations
  Central nervous system involvement in cryptococcal infection in individuals after solid organ transplantation or with AIDS.
  John A. Davis, David Horn, Kieren A. Marr, Jay A. Fishman> ;Transplant Infectious Disease. 2009 Oct 1
• 23 citations
  Epidemiology and outcome of multiple-species candidemia at a tertiary care center between 2004 and 2007
  Heather L. Nace, David Horn, Dionissios Neofytos> ;Diagnostic Microbiology and Infectious Disease. 2009 Jul 1
• 641 citations
  Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry
  David Horn, Dionissios Neofytos, Elias Anaissie, Jay A. Fishman, William J. Steinbach, Ali J. Olyaei, Kieren A. Marr, Michael A. Pfaller, Chi Hsing Chang, K. Webster> ;Clinical Infectious Diseases. 2009 Jun 15
• 26 citations
  Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection
  Michael J. Klevay, David Horn, Dionissios Neofytos, Michael A. Pfaller, Daniel J. Diekema> ;Diagnostic Microbiology and Infectious Disease. 2009 Jun 1
• 29 citations
  Aspergillus osteomyelitis: review of 12 cases identified by the Prospective Antifungal Therapy Alliance registry
  David Horn, Sutthichai Sae-Tia, Dionissios Neofytos> ;Diagnostic Microbiology and Infectious Disease. 2009 Apr 1
• 28 citations
  Candidemia in the 21st century
  Amy Chang, Dionissios Neofytos, David Horn> ;Future Microbiology. 2008 Jul 23
• 19 citations
  Brain abscess and hereditary hemorrhagic telangiectasia.
  Bevin Sell, James J. Evans, David Horn> ;Southern Medical Journal. 2008 Jun 1
• 63 citations
  Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections.
  David Horn, Jay A. Fishman, William J. Steinbach, Elias Anaissie, Kieren A. Marr, Ali J. Olyaei, Michael A. Pfaller, Mark Weiss, K. Webster, Dionissios Neofytos> ;Diagnostic Microbiology and Infectious Disease. 2007 Dec 1
• 26 citations
  Visual‐Motor Integration Skills of Prelingually Deaf Children: Implications for Pediatric Cochlear Implantation
  David L. Horn, Mary K. Fagan, Caitlin M. Dillon, David B. Pisoni, Richard T. Miyamoto> ;The Laryngoscope. 2007 Nov 1
• 449 citations
  Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis
  Peter G. Pappas, Coleman Rotstein, Robert F. Betts, Marcio Nucci, Deepak Talwar, Jan J. De Waele, Jose A. Vazquez, Bertrand Dupont, David Horn, Luis Ostrosky-Zeichner,...> ;Clinical Infectious Diseases. 2007 Oct 1
• Join now to see all